Study of Bevacizumab With Different Manufacturing Process in Healthy Male

See also
Status	Clinical Trial	Phase
Completed	`NCT05621447` - A Mass Balance Study of [14C] TAS-303 in Healthy Adult Male Subjects	Phase 1
Completed	`NCT02901366` - Mass Balance Study of FYU-981	Phase 2
Not yet recruiting	`NCT01928563` - Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Dapoxetine	Phase 1
Completed	`NCT05559554` - A Study to Evaluate the PK Similarity of AK104 in Healthy Chinese Male Subjects	Phase 1
Completed	`NCT04512872` - A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male Subjects	Phase 1
Active, not recruiting	`NCT06111196` - Compare the Pharmacokinetics and Safety of BAT3306 Injection Versus KEYTRUDA® Administered in Healthy Male Subjects	Phase 1
Completed	`NCT03317652` - Effect of Sodium Nitroprusside on Cerebral Blood Flow	N/A
Completed	`NCT04655872` - Mass Balance of Oral [14C]TPN171H in Healthy Male Subjects	Phase 1
Active, not recruiting	`NCT02609711` - Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male Sugjects	Phase 1
Withdrawn	`NCT02560363` - A Study to Compare the Pharmacokinetics of Different Formulations of AZD9977 and the Influence of Food in Healthy Male Subjects	Phase 1
Completed	`NCT01261260` - Effect of Uridine on GABA and High Energy Phosphate Levels in Healthy Volunteers	Phase 1
Completed	`NCT05072028` - Mass Balance and Biotransformation Study of [14C]DBPR108 in Human	Phase 1
Completed	`NCT05446233` - ADME Study of [14C] Antaitavir Hasophate in Healthy Male Subjects	Phase 1
Completed	`NCT05275010` - A Study in Healthy Male Subjects to Investigate the Comparability of Pharmacokinetics of the Fixed-Dose Combination of Pertuzumab and Trastuzumab Administered Subcutaneously Using a Handheld Syringe or Using the On-Body Delivery System	Phase 1
Completed	`NCT04839744` - A Comparative Study of TG103 Produced by Two Manufacturing Processes in Chinese Healthy Male Subjects	Phase 1
Completed	`NCT05792917` - Bioequivalence Study of Tafolecimab Injections in Chinese Healthy Male Volunteers	Phase 1
Completed	`NCT03576651` - A Study to Compare the Pharmacokinetics of JHL1149 and Bevacizumab (Avastin) in Healthy Male Volunteers	Phase 1
Completed	`NCT04825431` - Mass Balance Study of [14C] TAS-205 in Healthy Volunteers	Phase 1
Completed	`NCT01819779` - Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=60)	Phase 1
Completed	`NCT05126784` - AVT03 With Prolia in Healthy Male Subjects	Phase 1

NCT number	NCT05005455
Study type	Interventional
Source	Innovent Biologics (Suzhou) Co. Ltd.
Contact
Status	Completed
Phase	Phase 1
Start date	July 30, 2021
Completion date	January 28, 2022

Study of Bevacizumab With Different Manufacturing Process in Healthy Male Subjects

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms